Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Kazumasa Hiroishi"'
Autor:
Koji Fujita, A. Nakajima, Takuma Higurashi, Yumi Inoh, Kenji Kanoshima, Taro Takahara, Kazumasa Hiroishi, Akiko Fuyuki, Kanji Ohkuma, Shiori Uchiyama, Hajime Nagase, Akihiko Kusakabe, Hiroshi Iida, Takashi Nonaka, Hidenori Ohkubo, Masahiko Inamori
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Although chronic constipation is common, colonic functional evaluating tests are uncommon. This study examines whether chronic constipation and gastrointestinal symptoms are correlated with the lateral diameter of the colon measured from MRI images.
Autor:
Noriho Iida, Kazumasa Hiroishi, Yasunari Nakamoto, Yohei Marukawa, Michio Imawari, Hidetoshi Nakagawa, Takeshi Terashima, Kazuya Kitamura, Masaaki Kitahara, Shuichi Kaneko, Eishiro Mizukoshi
Publikováno v:
Cancer Immunology, Immunotherapy. 63:347-356
金沢大学先進予防医学研究センター / 金沢大学医薬保健研究域医学系
Radiofrequency ablation therapy (RFA) is a radical treatment for liver cancers and induces tumor antigen-specific immune responses. In the present stud
Radiofrequency ablation therapy (RFA) is a radical treatment for liver cancers and induces tumor antigen-specific immune responses. In the present stud
Autor:
Ayako Hiraide-Sasagawa, Michio Imawari, Junichi Eguchi, Masaaki Shiina, Yuichi Hirayama, Eiichi Hayashi, Kenichi Morikawa, Atsushi Kajiwara, Shigeaki Ishii, Hiroyoshi Doi, Risa Omori, Tomoe Shimazaki, Kazumasa Hiroishi, Masashi Sakaki
Publikováno v:
Hepatology Research. 45:1152-1154
Autor:
Shigeaki Ishii, Michio Imawari, Risa Omori, Junichi Eguchi, M Kogo, Ayako Hiraide, Takayoshi Ito, Masashi Sakaki, Hiroyoshi Doi, Kazumasa Hiroishi, Atsushi Kajiwara
Publikováno v:
Cancer Gene Therapy. 19:637-643
Interferon-alpha (IFN-α) has strong antitumor effects, and IFN-α gene therapy has been used clinically against some cancers. In this study, we evaluated the efficacy of the combination of IFN-α-transduced tumor cell vaccines and programmed cell de
Autor:
Shuntaro Obi, Kazuhide Yamamoto, Isao Sakaida, Shiro Miyayama, Masao Honda, Yasunari Nakamoto, Kenji Ikeda, Osamu Yokosuka, Yoshiyuki Ueno, Michio Sata, Shuhei Nishiguchi, Hisataka Moriwaki, Goshi Shiota, Shuichi Kaneko, Junji Furuse, Masatoshi Kudo, Yukinori Imai, Tetsuo Takehara, Morikazu Onchi, Kazumasa Hiroishi
Publikováno v:
Hepatology Research. 42:523-542
The "Guideline on the Use of New Anticancer Drugs for the Treatment of Hepatocellular Carcinoma" was prepared by the Study Group on New Liver Cancer Therapies established by the "Research Project on Emergency Measures to Overcome Hepatitis" under the
Autor:
Hisako Nozawa, Atsushi Kajiwara, Hiromitsu Kumada, Kazumasa Hiroishi, Mariko Kobayashi, Miyuki Miyashita, Michio Imawari, Takayoshi Ito, Masashi Sakaki
Publikováno v:
Journal of Viral Hepatitis. 19:608-614
Summary. Cyclooxygenase (COX)-2 is involved in inflammation, anti-apoptosis and carcinogenesis. The -1195GG genotype of single nucleotide polymorphism (SNP) in COX-2 promoter was associated with low platelet counts in patients with chronic hepatitis
Autor:
Ayako Sasagawa, Michio Imawari, Hiroyoshi Doi, Junichi Eguchi, Masashi Sakaki, Kazumasa Hiroishi, Risa Omori, Atsushi Kajiwara, Shigeaki Ishii
Publikováno v:
The Showa University Journal of Medical Sciences. 24:127-137
Autor:
Kazumasa Hiroishi, Miyuki Miyashita, Yuu Shimozuma, Tomoe Shimazaki, Manabu Uchikoshi, Jun Arai, Takayoshi Ito, Momoko Inokuchi, Michio Imawari, Kenichi Morikawa, Hisako Nozawa
Publikováno v:
Journal of Viral Hepatitis. 19:254-262
Summary. Hepatitis C virus (HCV) infects and associates with B cells, leading to abnormal B-cell activation and development of lymphoproliferative and autoimmune disorders. This immune perturbation may in turn be associated with the resistance of HCV
Autor:
Momoko Inokuchi, Takayoshi Ito, Hisako Nozawa, Manabu Uchikoshi, Michio Imawari, Tomoe Shimazaki, Yuu Shimozuma, Kazumasa Hiroishi, Miyuki Miyashita
Publikováno v:
Journal of Medical Virology. 82:2064-2072
Hepatitis C virus (HCV) infection is associated with lymphoproliferative disorders. HCV infection of B cells is a predictive factor for lymphoproliferative disorders in patients with chronic hepatitis C, although its molecular mechanisms remain unkno
Autor:
Risa Omori, Ayako Hiraide, Kazumasa Hiroishi, Junichi Eguchi, Reiko Makino, Masashi Sakaki, Michio Imawari, Hiroyoshi Doi, Kumiko Ueda
Publikováno v:
Hepatology Research. 40:1219-1226
Aim: Because polymorphisms of cyclooxygenase-2 (COX-2) and osteopontin (OPN) promoter regions and a promoter/enhancer region of forkhead box protein 3 (FOXP3) gene are known to affect immune responses, we examined whether these polymorphisms can infl